-
Communities
-
Explore Vanderbilt communities
By latest
Featured community
Creative Data Solutions (CDS) is a Vanderbilt Shared Resource and has extensive experience in providing effective and robust solutions to challenges pertaining to research data using modern informatics and bioinformatics approaches.
-
- Resources
-
People
-
Publications
-
Explore publications
-
Keyword Connections
Connections to 3,4-Methylenedioxyamphetamine are shown below. Double-click or tap a node for more information.
Please note that publication matches are limited to 40 in this view. If you expected more, please view all publication matches for 3,4-Methylenedioxyamphetamine.
Members
- No matching connections
Resources
- No matching connections
Communities
- No matching connections
Publications
- Human Ecstasy use is associated with increased cortical excitability: an fMRI study.
Bauernfeind AL, Dietrich MS, Blackford JU, Charboneau EJ, Lillevig JG, Cannistraci CJ, Woodward ND, Cao A, Watkins T, Di Iorio CR, Cascio C, Salomon RM, Cowan RL
(2011) Neuropsychopharmacology 36: 1127-41 - Pineal serotonin is resistant to depletion by serotonergic neurotoxins in rats.
Champney TH, Matthews RT
(1991) J Pineal Res 11: 163-7 - Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism.
Baucum AJ, Rau KS, Riddle EL, Hanson GR, Fleckenstein AE
(2004) J Neurosci 24: 3436-43 - The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans.
Hysek CM, Simmler LD, Ineichen M, Grouzmann E, Hoener MC, Brenneisen R, Huwyler J, Liechti ME
(2011) Clin Pharmacol Ther 90: 246-55 - Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects.
Simmler LD, Hysek CM, Liechti ME
(2011) J Clin Endocrinol Metab 96: 2844-50 - Prior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study.
Karageorgiou J, Dietrich MS, Charboneau EJ, Woodward ND, Blackford JU, Salomon RM, Cowan RL
(2009) Neuroimage 46: 817-26 - The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics.
Meredith EJ, Holder MJ, Chamba A, Challa A, Drake-Lee A, Bunce CM, Drayson MT, Pilkington G, Blakely RD, Dyer MJ, Barnes NM, Gordon J
(2005) FASEB J 19: 1187-9 - Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.
Hysek C, Schmid Y, Rickli A, Simmler LD, Donzelli M, Grouzmann E, Liechti ME
(2012) Br J Pharmacol 166: 2277-88 - Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants.
Henry LK, Field JR, Adkins EM, Parnas ML, Vaughan RA, Zou MF, Newman AH, Blakely RD
(2006) J Biol Chem 281: 2012-23 - Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine.
Field JR, Henry LK, Blakely RD
(2010) J Biol Chem 285: 11270-80 - Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.
Watkins TJ, Raj V, Lee J, Dietrich MS, Cao A, Blackford JU, Salomon RM, Park S, Benningfield MM, Di Iorio CR, Cowan RL
(2013) Psychopharmacology (Berl) 227: 41-54 - Effects of the α₂-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers.
Hysek CM, Brugger R, Simmler LD, Bruggisser M, Donzelli M, Grouzmann E, Hoener MC, Liechti ME
(2012) J Pharmacol Exp Ther 340: 286-94 - Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study.
Hysek CM, Simmler LD, Nicola VG, Vischer N, Donzelli M, Krähenbühl S, Grouzmann E, Huwyler J, Hoener MC, Liechti ME
(2012) PLoS One 7: e36476 - α₁-Adrenergic receptors contribute to the acute effects of 3,4-methylenedioxymethamphetamine in humans.
Hysek CM, Fink AE, Simmler LD, Donzelli M, Grouzmann E, Liechti ME
(2013) J Clin Psychopharmacol 33: 658-66 - Drugs, biogenic amine targets and the developing brain.
Frederick AL, Stanwood GD
(2009) Dev Neurosci 31: 7-22 - MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study.
Raj V, Liang HC, Woodward ND, Bauernfeind AL, Lee J, Dietrich MS, Park S, Cowan RL
(2010) J Psychopharmacol 24: 187-201 - Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats.
Matthews RT, Champney TH, Frye GD
(1989) Pharmacol Biochem Behav 33: 741-7
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.
